Skip to main content

Table 2 Group A (Orchidectomy) lipid profile data

From: The impact of androgen deprivation therapy on the lipid profile in patients with prostate carcinoma

  Baseline(A) 6 month(B) 12 month(C)* 24 month(D)* p value
Total cholesterol 180.6 ± 19.8 195.7 ± 28.3 189.4 ± 24.6 189.1 ± 24.5 0.14
Triglycerides 103.1 ± 29.8 111.1 ± 28.7 112.1 ± 29.2 112.5 ± 29.6 0.57
HDL-cholesterol 48.5 ± 7.9 50.5 ± 6.3 49.5 ± 6.4 48.9 ± 6.3 0.70
LDL-cholesterol 111.4 ± 19.4 124.3 ± 26.5 119.4 ± 22.7 119.8 ± 21.9 0.19
VLDL-cholesterol 20.2 ± 3.8 20.8 ± 2.8 20.5 ± 2.7 20.6 ± 2.5 0.87
  1. PSA prostate-specific antigen, HDL high-density lipoprotein, LDL low-density lipoprotein, VLDL very low-density lipoprotein
  2. *n = 28, data in mean ± SD